258 related articles for article (PubMed ID: 16519507)
1. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
Li T; Paudel HK
Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9.
Li T; Paudel HK
Neurosci Lett; 2007 Mar; 414(3):203-8. PubMed ID: 17317006
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain.
Yuan Z; Agarwal-Mawal A; Paudel HK
J Biol Chem; 2004 Jun; 279(25):26105-14. PubMed ID: 15073173
[TBL] [Abstract][Full Text] [Related]
5. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.
Cho JH; Johnson GV
J Biol Chem; 2003 Jan; 278(1):187-93. PubMed ID: 12409305
[TBL] [Abstract][Full Text] [Related]
7. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.
Sen T; Saha P; Jiang T; Sen N
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4418-4427. PubMed ID: 32051249
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
10. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules.
Cho JH; Johnson GV
J Neurochem; 2004 Jan; 88(2):349-58. PubMed ID: 14690523
[TBL] [Abstract][Full Text] [Related]
11. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
12. Thr175-phosphorylated tau induces pathologic fibril formation via GSK3β-mediated phosphorylation of Thr231 in vitro.
Moszczynski AJ; Gohar M; Volkening K; Leystra-Lantz C; Strong W; Strong MJ
Neurobiol Aging; 2015 Mar; 36(3):1590-9. PubMed ID: 25573097
[TBL] [Abstract][Full Text] [Related]
13. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models.
Matthews TA; Johnson GV
Neurosci Lett; 2005 Aug; 384(3):211-6. PubMed ID: 15963640
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT.
Kyoung Pyo H; Lovati E; Pasinetti GM; Ksiezak-Reding H
Neuroscience; 2004; 127(3):649-58. PubMed ID: 15283964
[TBL] [Abstract][Full Text] [Related]
16. GSK-3beta directly phosphorylates and activates MARK2/PAR-1.
Kosuga S; Tashiro E; Kajioka T; Ueki M; Shimizu Y; Imoto M
J Biol Chem; 2005 Dec; 280(52):42715-22. PubMed ID: 16257959
[TBL] [Abstract][Full Text] [Related]
17. GSK3 and tau: two convergence points in Alzheimer's disease.
Hernandez F; Lucas JJ; Avila J
J Alzheimers Dis; 2013; 33 Suppl 1():S141-4. PubMed ID: 22710914
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
[TBL] [Abstract][Full Text] [Related]
19. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
Chun W; Waldo GS; Johnson GV
J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
[TBL] [Abstract][Full Text] [Related]
20. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.
Ksiezak-Reding H; Pyo HK; Feinstein B; Pasinetti GM
Biochim Biophys Acta; 2003 Nov; 1639(3):159-68. PubMed ID: 14636947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
